BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 9229367)

  • 1. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
    Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
    Somers E; Magder LS; Petri M
    J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.
    Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S
    Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
    Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
    Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
    Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
    Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between IgM anticardiolipin antibodies and deep venous thrombosis in patients without systemic lupus erythematosus.
    Oger E; Lernyer C; Dueymes M; Le Moigne E; Bressolette L; Escoffre M; Youinou P; Mottier D
    Lupus; 1997; 6(5):455-61. PubMed ID: 9229365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
    Forastiero RR; Kordich L; Basilotta E; Carreras LO
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis.
    Sobanski V; Lemaire-Olivier A; Giovannelli J; Dauchet L; Simon M; Lopez B; Yelnik C; Lambert M; Hatron PY; Hachulla E; Dubucquoi S; Launay D
    Front Immunol; 2018; 9():2457. PubMed ID: 30464761
    [No Abstract]   [Full Text] [Related]  

  • 13. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.
    Neville C; Rauch J; Kassis J; Solymoss S; Joseph L; Belisle P; Subang R; Chang ER; Fortin PR
    Rheumatology (Oxford); 2006 Sep; 45(9):1116-20. PubMed ID: 16510527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis.
    Wahl DG; Guillemin F; de Maistre E; Perret-Guillaume C; Lecompte T; Thibaut G
    Lupus; 1998; 7(1):15-22. PubMed ID: 9493144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent antiphospholipid-related deep vein thrombosis as presenting manifestation of systemic lupus erythematosus.
    Gattorno M; Molinari AC; Buoncompagni A; Acquila M; Amato S; Picco P
    Eur J Pediatr; 2000 Mar; 159(3):211-4. PubMed ID: 10664237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus.
    Martini F; Farsi A; Gori AM; Boddi M; Fedi S; Domeneghetti MP; Passaleva A; Prisco D; Abbate R
    Lupus; 1996 Jun; 5(3):206-11. PubMed ID: 8803891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
    Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
    Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant.
    Nojima J; Suehisa E; Akita N; Toku M; Fushimi R; Tada H; Kuratsune H; Machii T; Kitani T; Amino N
    Br J Haematol; 1997 Mar; 96(3):447-50. PubMed ID: 9054646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.